Produção Nacional
Revisado por pares
Differentiated thyroid carcinomas and their B7H1 shield
2013; Future Medicine; Volume: 9; Issue: 10 Linguagem: Inglês
10.2217/fon.13.89
ISSN1744-8301
AutoresLucas Leite Cunha, Marjory Alana Marcello, José Vassallo, Laura Sterian Ward,
Tópico(s)Ferroptosis and cancer prognosis
ResumoFuture OncologyVol. 9, No. 10 EditorialDifferentiated thyroid carcinomas and their B7H1 shieldLucas Leite Cunha, Marjory Alana Marcello, José Vassallo & Laura Sterian WardLucas Leite CunhaLaboratory of Cancer Molecular Genetics, Faculty of Medical Sciences – University of Campinas (Unicamp). 126, Tessalia Vieira de Camargo Street, Campinas, SP, Brazil, Marjory Alana MarcelloLaboratory of Cancer Molecular Genetics, Faculty of Medical Sciences – University of Campinas (Unicamp). 126, Tessalia Vieira de Camargo Street, Campinas, SP, Brazil, José VassalloDepartment of Pathology, A. C. Camargo Cancer Hospital. 211, Antonio Prudente Street, São Paulo, SP, Brazil.Laboratory of Investigative & Molecular Pathology (Ciped), Faculty of Medical Sciences – University of Campinas (Unicamp). 126, Tessalia Vieira de Camargo Street, Campinas, SP, Brazil. & Laura Sterian Ward* Author for correspondenceLaboratory of Cancer Molecular Genetics, Faculty of Medical Sciences – University of Campinas (Unicamp). 126, Tessalia Vieira de Camargo Street, Campinas, SP, Brazil. Published Online:9 Oct 2013https://doi.org/10.2217/fon.13.89AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail View articleKeywords: B7H1differentiated thyroid carcinomatumor immunologyReferences1 Muzza M, Degl'innocenti D, Colombo C et al. The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clin. Endocrinol.72(5),702–708 (2010).Crossref, Medline, CAS, Google Scholar2 De Vries AC, Van Grieken NC, Looman CW et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in The Netherlands. Gastroenterology134(4),945–952 (2008).Crossref, Medline, Google Scholar3 Cunha LL, Tincani AJ, Assumpcao LV, Soares FA, Vassallo J, Ward LS. Interleukin-10 but not interleukin-18 may be associated with the immune response against well-differentiated thyroid cancer. Clinics66(7),1203–1208 (2011).Crossref, Medline, Google Scholar4 Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J. Clin.63(1),11–30 (2013).Crossref, Medline, Google Scholar5 Kantoff PW, Higano CS, Shore ND et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N. Engl. J. Med.363(5),411–422 (2010).Crossref, Medline, CAS, Google Scholar6 Hodi FS, O'Day SJ, McDermott DF et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med.363(8),711–723 (2010).Crossref, Medline, CAS, Google Scholar7 Brahmer JR, Tykodi SS, Chow LQ et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N. Engl. J. Med.366(26),2455–2465 (2012).Crossref, Medline, CAS, Google Scholar8 Cunha LL, Ward LS. Concurrent lymphocytic thyroiditis is associated to less aggressive papillary thyroid carcinomas. Eur. Arch. Otorhinolaryngol.269(2),699–700 (2012).Crossref, Medline, Google Scholar9 Gogali F, Paterakis G, Rassidakis GZ et al. Phenotypical analysis of lymphocytes with suppressive and regulatory properties (Tregs) and NK cells in the papillary carcinoma of thyroid. J. Clin. Endocrinol. Metab.97(5),1474–1482 (2012).Crossref, Medline, CAS, Google Scholar10 French JD, Weber ZJ, Fretwell DL, Said S, Klopper JP, Haugen BR. Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer. J. Clin. Endocrinol. Metab.95(5),2325–2333 (2010).Crossref, Medline, CAS, Google Scholar11 Zhou G, Drake CG, Levitsky HI. Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines. Blood107(2),628–636 (2006).Crossref, Medline, CAS, Google Scholar12 Hamanishi J, Mandai M, Iwasaki M et al. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer. Proc. Natl Acad. Sci. USA104(9),3360–3365 (2007).Crossref, Medline, CAS, Google Scholar13 Dong H, Strome SE, Salomao DR et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med.8(8),793–800 (2002).Crossref, Medline, CAS, Google Scholar14 Thompson RH, Kuntz SM, Leibovich BC et al. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res.66(7),3381–3385 (2006).Crossref, Medline, CAS, Google Scholar15 Cunha LL, Marcello MA, Morari EC et al. Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation. Endocr. Relat. Cancer20(1),103–110 (2013).Crossref, Medline, CAS, Google Scholar16 Routh JC, Ashley RA, Sebo TJ et al. B7-H1 expression in Wilms tumor: correlation with tumor biology and disease recurrence. J. Urol.179(5),1954–1960 (2008).Crossref, Medline, Google Scholar17 Yao Y, Tao R, Wang X, Wang Y, Mao Y, Zhou LF. B7-H1 is correlated with malignancy-grade gliomas but is not expressed exclusively on tumor stem-like cells. Neuro. Oncol.11(6),757–766 (2009).Crossref, Medline, Google Scholar18 French JD, Kotnis GR, Said S et al. Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer. J. Clin. Endocrinol. Metab.97(6),e934–e943 (2012).Crossref, Medline, CAS, Google Scholar19 Fife BT, Pauken KE, Eagar TN et al. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat. Immunol.10(11),1185–1192 (2009).Crossref, Medline, CAS, Google Scholar20 Iwai Y, Ishida M, Tanaka Y, Okazaki T, Honjo T, Minato N. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc. Natl Acad. Sci. USA99(19),12293–12297 (2002).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByReceptor–ligand pair typing and prognostic risk model for papillary thyroid carcinoma based on single-cell sequencing22 July 2022 | Frontiers in Immunology, Vol. 13Update regarding the role of PD-L1 in oncocytic thyroid lesions on cytological samples14 June 2022 | Journal of Clinical Pathology, Vol. 366The immune landscape of the microenvironment of thyroid cancer is closely related to differentiation status20 July 2021 | Cancer Cell International, Vol. 21, No. 1PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cells7 January 2021 | Journal of Experimental & Clinical Cancer Research, Vol. 40, No. 1PD‐L1 and thyroid cytology: A possible diagnostic and prognostic marker10 December 2019 | Cancer Cytopathology, Vol. 128, No. 3Interleukin 10 expression is related to aggressiveness and poor prognosis of patients with thyroid cancer17 November 2016 | Cancer Immunology, Immunotherapy, Vol. 66, No. 2Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer2 March 2016 | Oncotarget, Vol. 7, No. 13The PD-1/B7-H1 Pathway Modulates the Natural Killer Cells versus Mouse Glioma Stem Cells12 August 2015 | PLOS ONE, Vol. 10, No. 8 Vol. 9, No. 10 eToC Sign up Follow us on social media for the latest updates Metrics Downloaded 116 times History Published online 9 October 2013 Published in print October 2013 Information© Future Medicine LtdKeywordsB7H1differentiated thyroid carcinomatumor immunologyFinancial & competing interests disclosureThis study was funded by the State of São Paulo Research Foundation (FAPESP). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.No writing assistance was utilized in the production of this manuscript.PDF download
Referência(s)